On Nov 16, 2021, Pfizer is seeking EUA from FDA for its new pill, Paxlovid, against Covid-19. It is going to be given together with an older antiviral drug and indicated to treat mild to moderate Covid-19. It has shown 89% reduction in risk of hospitalization or death from Covid-19 if given with 3 days of symptom onset. Read the full article here